Modeling the population health benefits of LDL-C reduction with alirocumab among cardiovascular disease/heterozygous familial hypercholesterolemia patients with elevated LDL-CRobert Sanchez,K. Nasir, A. Klimchak,A. Kuznik, F. Joulain,A. BriggsATHEROSCLEROSIS（2018）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
